Long-term follow up of a "sporadic" unilateral pheochromocytoma revealing multiple endocrine neoplasia MEN2A-2 in an elderly woman

scientific article published on January 2003

Long-term follow up of a "sporadic" unilateral pheochromocytoma revealing multiple endocrine neoplasia MEN2A-2 in an elderly woman is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P6179Dimensions Publication ID1030578981
P356DOI10.1385/EP:14:4:375
P698PubMed publication ID14739494

P2093author name stringAndreas Weinhäusel
Alois Gessl
Bruce A J Ponder
Roswitha Pfragner
Oskar A Haas
Heinrich Vierhapper
Bruno Niederle
Annemarie Behmel
P2860cites workMutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and hirschsprung diseaseQ28305753
Pheochromocytoma in multiple endocrine neoplasia type 2: a prospective study.Q31928758
The phenotypes associated with ret mutations in the multiple endocrine neoplasia type 2 syndrome.Q33590925
Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomasQ33682913
RET proto-oncogene in the development of human cancerQ33718087
Pheochromocytoma: inherited associations, bilaterality, and cortex preservationQ34103572
Germ-line mutations in nonsyndromic pheochromocytomaQ34523021
Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau diseaseQ34726998
Expression analysis of RET and the GDNF/GFRalpha-1 and NTN/GFRalpha-2 ligand complexes in pheochromocytomas and paragangliomasQ40853448
First continuous human pheochromocytoma cell line: KNA. Biological, cytogenetic and molecular characterization of KNA cellsQ40905421
The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysisQ40920116
A novel case of multiple endocrine neoplasia type 2A associated with two de novo mutations of the RET protooncogeneQ40922879
Low frequency of germline mutations in the RET proto‐oncogene in patients with apparently sporadic medullary thyroid carcinomaQ40980321
Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease.Q41021579
Seminars in medicine of the Beth Israel Hospital, Boston. The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung's diseaseQ41091439
Extensive mutation scanning of RET in sporadic medullary thyroid carcinoma and of RET and VHL in sporadic pheochromocytoma reveals involvement of these genes in only a minority of cases.Q41180363
Germline mutation of RET codon 883 in two cases of de novo MEN 2B.Q48045271
Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. "Study Group Multiple Endocrine Neoplasia Austria (SMENA)".Q50752866
Differences between sporadic and multiple endocrine neoplasia type 2A phaeochromocytoma.Q50890372
Pheochromocytoma in multiple endocrine neoplasia type 2: European studyQ62978347
A RET double mutation in the germline of a kindred with FMTC.Q64992218
Diagnosis and management of pheochromocytomas in patients with multiple endocrine neoplasia type 2-relevance of specific mutations in the RET proto-oncogeneQ71540782
The RET proto-oncogene in sporadic pheochromocytomasQ71603189
Expression of the ret proto-oncogene in phaeochromocytoma. An in situ hybridization and northern blot studyQ71895470
Phaeochromocytoma in multiple endocrine neoplasia type 2 A: survey of 100 casesQ72225417
A duplication of 12 bp in the critical cysteine rich domain of the RET proto-oncogene results in a distinct phenotype of multiple endocrine neoplasia type 2AQ73211985
[Pheochromocytoma associated with multiple endocrine neoplasia 2A and sporadic: differential characteristics]Q73229941
Duplication of the mutant RET allele in trisomy 10 or loss of the wild-type allele in multiple endocrine neoplasia type 2-associated pheochromocytomasQ73263319
Genetic testing in medullary thyroid carcinoma syndromes: mutation types and clinical significanceQ73330043
Differential genetic alterations in von Hippel-Lindau syndrome-associated and sporadic pheochromocytomasQ73336672
A patient with MEN 2 and multiple mutations of RET in the germlineQ73375001
Genetic alterations of the RET proto-oncogene in familial and sporadic pheochromocytomasQ73377914
Sporadic pheochromocytomas are rarely associated with germline mutations in the vhl tumor suppressor gene or the ret protooncogeneQ73941283
Duplication of 9 base pairs in the critical cysteine-rich domain of the RET proto-oncogene causes multiple endocrine neoplasia type 2AQ74127739
A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2AQ74324586
Prognostic value of RET proto-oncogene point mutations in malignant and benign, sporadic phaeochromocytomasQ77371914
P433issue4
P921main subjectphaeochromocytomaQ536269
multiple endocrine neoplasiaQ1553018
P304page(s)375-382
P577publication date2003-01-01
P1433published inEndocrine PathologyQ15757049
P1476titleLong-term follow up of a "sporadic" unilateral pheochromocytoma revealing multiple endocrine neoplasia MEN2A-2 in an elderly woman
P478volume14

Reverse relations

cites work (P2860)
Q37587164Neuroendocrine tumors and tumor syndromes in childhood
Q49852319Pathology and genetics of phaeochromocytoma and paraganglioma
Q36712963Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005.
Q33842300Prevalence by age and predictors of medullary thyroid cancer in patients with lower risk germline RET proto-oncogene mutations.

Search more.